Fig. S1. Expression of E2-2 mRNA upon ALK6 activation.

Fig. S2. Effect of vascular endothelial growth factor (VEGF) on expression of FAM96B.

Fig. S3. Effect of FAM96B on expression of c-Myc protein.

Fig. S4. Effect of proteasome inhibitors on FAM96B-mediated decrease of E2-2 protein.

Fig. S5. Effect of a lysosome inhibitor on FAM96B-mediated decrease of E2-2 protein.

Table S1. Polymerase chain reaction primers to amplify mouse cDNAs.

CAS_2022_sm_fS1.TIF136KSupporting info item
CAS_2022_sm_fS2.TIF125KSupporting info item
CAS_2022_sm_fS3.TIF99KSupporting info item
CAS_2022_sm_fS4.TIF133KSupporting info item
CAS_2022_sm_fS5.TIF143KSupporting info item
CAS_2022_sm_tS1.TIF73KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.